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Oocytes secrete soluble factors that regulate the growth and differentiation of follicular cells, including maintenance of the
distinctive cumulus cell phenotype. This study determines whether the mitogenic activity of oocytes is developmentally
regulated and examines the responsiveness of follicular cells to oocytes at different stages of follicular development.
Prepubertal SV129 mice of varying ages were primed with 5 IU equine chorionic gonadotropin (eCG) and oocytes/zygotes
collected either 46 h post-eCG (immature oocytes), 12 h after administration of 5 IU human CG (hCG; ovulated ova), or 12 h
post-hCG and mating (zygotes). Mural granulosa cells (MGC) from antral follicles and GC from preantral follicles were
cultured 6 denuded oocytes (DO) for 18 h, followed by a 6-h pulse of [3H]thymidine as an indicator of cellular DNA
ynthesis. Coculturing MGC with meiotically maturing oocytes led to a dose-dependent increase in [3H]thymidine
incorporation (20-fold above control levels at 0.5 DO/ml). However, [3H] counts remained unchanged from control levels
when cultured with meiotically incompetent DO from 11- to 15-day-old mice (3% germinal vesicle breakdown; GVB),
irrespective of dose of DO or developmental status of GC (MGC or preantral GC). In some treatments, spontaneous meiotic
resumption of competent oocytes was prevented by culturing with 5 mM milrinone, a selective inhibitor of oocyte-specific
cyclic nucleotide phosphodiesterase. The mitogenic capacity of oocytes was found to decline during and after oocyte
maturation. [3H]Thymidine incorporation in MGC was highest (11-fold above controls) when cultured with meiotically
nhibited (milrinone-treated) GV DO, stimulated 5.5-fold by culture with maturing oocytes, 3-fold with ovulated ova, and
nstimulated by zygotes. [3H]Thymidine incorporation in MGC was not altered by the dose of milrinone, either in the
resence or absence of DO. Metaphase I marked the beginning of the decline in the capacity of oocytes to promote MGC
NA synthesis. These results demonstrate that the capacity of oocytes to promote proliferation of granulosa cells follows
developmental program, closely linked to oocyte meiotic status, increasing with the acquisition of meiotic competence
nd declining during and after oocyte maturation. © 2001 Academic Press
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lINTRODUCTION
Oocyte–follicular cell interaction is a bidirectional pro-
cess: not only does the follicular environment determine to
a large extent the developmental capacity of the oocyte, but
also paracrine signals from the oocyte play a critical role in
the growth and development of the follicular compartment.
Follicle growth and development fail in the absence of the
oocyte, whether lacking due to genetic deficiencies or
experimental ablation. Oocytes were first implicated in the
1 To whom correspondence should be addressed. Fax: 161 8
k82227521. E-mail: robert.gilchrist@adelaide.edu.au.
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All rights of reproduction in any form reserved.egulation of follicular cells by findings that surgical re-
oval of oocytes from preovulatory rabbit follicles causes
pontaneous luteinization (el-Fouly et al., 1970). It is now
nown that oocyte-derived factors modulate a broad range
f follicular cell functions, including: cumulus cell mucifi-
ation and hyaluronic acid production (Buccione et al.,
990; Salustri et al., 1990b); cellular proliferation (Vander-
yden et al., 1992; Lanuza et al., 1998; Li et al., 2000);
teroid (Vanderhyden et al., 1993) and inhibin synthesis
Lanuza et al., 1999); and mRNA expression of urokinase-
ype plasminogen activator (uPA; Canipari et al., 1995),
uteinizing hormone receptor (LHR; Eppig et al., 1997), and
it-ligand (KL; Joyce et al., 1999). Despite considerable
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290 Gilchrist, Ritter, and Armstrongefforts to characterize these oocyte-derived factor(s), their
true identity remains elusive. To date, the best candidates
are members of the transforming growth factor-b (TGFb)
uperfamily; including TGFb1 (Salustri et al., 1990a),
rowth-differentiation factor-9 (GDF-9; Elvin et al., 1999),
nd bone morphogenic protein-15 (BMP-15; Otsuka et al.,
000), as these oocyte-secreted proteins are able to mimic
any of the effects of oocytes on follicular cells.
Two of these identified oocyte-derived growth factors are
ssential for normal follicle development as GDF-9-
eficient female mice (Dong et al., 1996) and BMP-15-
eficient ewes (Galloway et al., 2000) are infertile due to a
omplete block in folliculogenesis at the primary follicle
tage. These animals exhibit remarkably similar ovarian
henotypes, characterised by small “streak ovaries” con-
aining a multitude of primordial and primary follicles and
lso tumor-like, oocyte-free granulosa cell nests (Dong et
l., 1996; Juengel et al., 2000). Interestingly, while ewes
omozygous for the Inverdale gene (which contains the
utation in the BMP-15 gene) are infertile, heterozygotes
ave an increased ovulation rate compared to wild-type
wes. Hence, while absence of oocyte GDF-9 or BMP-15
ause dramatically altered gene expression in follicular
ells leading to perturbed folliculogenesis and sterility,
osage of oocyte BMP-15 affects fecundity in fertile ani-
als.
The capacity of oocytes to alter granulosa cell functions
s developmentally regulated, depending on the stage of
ocyte growth and maturation, the developmental state of
he granulosa cells, and the oocyte factor in question. In
eneral terms, growing meiotically incompetent oocytes
re less effective in regulating follicular cell functions than
ully grown oocytes, even though growing oocytes have
een shown to contain GDF-9 (Elvin et al., 1999; Jaatinen et
l., 1999) and BMP-15 proteins (Otsuka et al., 2000). For
xample, growing mouse oocytes do not produce cumulus
xpansion-enabling factor (CEEF) and are not able to sup-
ress uPA or KL synthesis (Vanderhyden et al., 1990;
anipari et al., 1995; Joyce et al., 2000), but are able to
egulate steroidogenesis and suppress LHR mRNA expres-
ion (Eppig et al., 1997; Vanderhyden and Macdonald, 1998).
ocyte CEEF, uPA-suppressor, and KL-suppressor activities
re acquired as oocytes achieve meiotic competence, and
re maintained throughout antral development and during
eiotic maturation, but are lost by the zygotic stage.
ocytes are also able to promote the proliferation of follicu-
ar granulosa cells (Vanderhyden et al., 1992), although the
evelopmental expression of this oocyte factor remains
nclear. Previous studies indicate that fully grown, meioti-
ally maturing oocytes secrete a potent mitogen to which
ll of the major granulosa cell phenotypes are able to
espond, including relatively undifferentiated granulosa
ells from preantral follicles, and differentiated mural
ranulosa cells and cumulus cells from antral follicles
Vanderhyden et al., 1992; Lanuza et al., 1998; Li et al.,
000). It is unknown whether small, growing oocytes are
ajor drivers of preantral follicle growth. It is also not
Copyright © 2001 by Academic Press. All rightnown how oocyte mitogenic activity is regulated in rela-
ion to the acquisition of meiotic capacity, nuclear status of
eiotically competent oocytes, or during early embryo
evelopment. Hence, the objectives of this study are to
xamine the developmental expression of oocyte mitogenic
apacity throughout folliculogenesis and oocyte meiotic
aturation. Evidence reported here demonstrates that the
itogenic capacity of oocytes is closely coupled to oocyte
eiotic competence and maturation status. Meiotically
ompetent, GV-stage oocytes exhibit the highest growth-
romoting activity, greater than growing oocytes, meioti-
ally maturing oocytes, or zygotes.
MATERIALS AND METHODS
Collection and Preparation of Granulosa Cells
Mice used in this study were maintained at The Queen Elizabeth
Hospital on a 14:10-h light:dark cycle with pelleted food and water
available ad libitum. This study was approved by local Animal
Ethics Committees and was conducted in accordance with the
Australian Code of Practice for the Care and Use of Animals for
Scientific Purposes. Reproductive tracts were collected from im-
mature SV129 mice of varying age depending on the experiment,
primed with 5 IU of equine chorionic gonadotrophin (eCG; Folli-
gon, Intervet, Castle Hill, Australia). Ovaries were dissected free of
adherent adipose and connective tissues and placed in 25 mM
Hepes-buffered tissue culture medium-199 (H-TCM; ICN, CA)
supplemented with 2 mM Na pyruvate (Sigma, St Louis, MO), 100
IU/ml Penicillin G (Sigma), and 100 mg/ml streptomycin sulfate
(Sigma) and 0.3 mg/ml polyvinyl alcohol (PVA; Sigma).
For the preparation of mural granulosa cells (MGC), ovaries were
obtained from 23- to 32-day-old mice 46 h after eCG treatment.
Large antral follicles in intact ovaries were punctured with a
27-gauge needle and MGC were gently squeezed from follicles. All
debris (stromal and thecal tissue, preantral follicles, and naked
oocytes) were carefully removed from the ovary puncture dishes,
and the remaining MGC were collected by centrifugation. Cells
were washed once in H-TCM and twice in culture media. Granu-
losa cells (GC) from small antral follicles and preantral follicles
were obtained by collecting follicular cells from mice as young as
11 days old by using a similar procedure to that of the older mice.
In general, these younger immature mice were also primed with
5IU eCG, although not in one experiment (see Table 2).
Preparation of Oocytes at Different Stages of
Development
Immature cumulus–oocyte complexes (COC) were collected
from punctured follicles at the same time as GC were collected.
Only COC with a uniform covering of compacted cumulus cells
and with a light and evenly pigmented ooplasm were used in this
study. Denuded oocytes (DO) completely devoid of cumulus cells
were generated by vortexing COC for ;2 min in H-TCM.
To determine at what stage of oocyte development an oocyte
mitogen is produced, oocytes were collected from follicles at
varying stages of development by collecting oocytes from mice of
varying prepubertal age. The mitogenic capacity of oocytes with
three differing degrees of meiotic competence were compared: (1)
growing, meiotically incompetent oocytes from preantral follicles,
s of reproduction in any form reserved.
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291Developmentally Coordinated Pattern of Oocyte Mitogenic Activitycollected from 11- to 15-day-old mice; (2) growing oocytes with low
meiotic competence from periantral follicles from 16- to 19-day-old
mice, and; (3) fully grown, meiotically competent oocytes from
antral follicles collected from 21- to 32-day-old mice (see Figs. 2 and
3, Table 2).
Meiotically competent oocytes were examined for their mito-
genic capacity at varying stages of meiotic maturation, and also
under conditions in which meiotic maturation was inhibited.
Spontaneous meiotic resumption was artificially inhibited by col-
lecting and culturing fully grown DO with 5 mM milrinone (Sigma),
a potent inhibitor of oocyte-specific type-3 phophodiesterases (see
Figs. 4 and 5).
Oocytes at different stages of maturation were generated by
partially or completely maturing meiotically competent oocytes
(either in vivo or in vitro), before addition to freshly collected
MGC. To generate discrete groups of meiotically synchronized
oocytes (see Fig. 6 for illustration of experimental design), four
groups of 24- to 28-day-old mice were primed with eCG at 3 hourly
intervals and then killed 46 h later. COC were collected and
denuded and then the first group was allowed to spontaneously
mature in culture medium (see below) in Nunc (Roskilda, Den-
mark) 4-well dishes for 9 h (treatment 1), the second group for 6 h
(treatment 2), the third for 3 h (treatment 3), and the fourth for 0 h
(treatment 4). The precultured oocytes, each group being at pro-
gressively advanced stages of meiosis, were then added to freshly
collected MGC at a concentration of 50 DO/well. After 3 h of
coculture, DO were removed from the wells and the remaining
MGC were cultured for a further 21 h. This experimental design
generated four treatment groups where MGC were exposed to
oocytes in four different, nonoverlapping phases of meiosis.
Ovulated in vivo matured oocytes and zygotes were collected
from oviducts of unmated or mated 23- to 32-day-old eCG-primed
mice, respectively, administered 5 IU of hCG (Pregnyl; Organon,
Sydney, Australia) 46 h after eCG treatment. Only ova with a polar
body or zygotes with two pronuclei were used. These mature
oocytes and zygotes were then added to freshly collected MGC and
compared to in vitro maturing and GV-arrested oocytes in terms of
their capacity to promote MGC DNA synthesis (see Fig. 4).
Culture Conditions and Experimental Set-Up
To determine cell numbers, a sample of GC was dissociated as
previously described (Luciano et al., 2000) and counted by using a
haemocytometer. For culture, GC were not dissociated but rather
cultured as clumps of cells (Luciano et al., 2000). Granulosa cells
were cultured at a density of approximately 25,000 GC/well in
bicarbonate-buffered TCM supplemented with PVA, 0.23 mM Na
pyruvate, and antibiotics (B-TCM) in 96-well plates (Falcon, Frank-
lin Lakes, NJ). Depending on the individual experiments, DO/
zygotes, hormones, reagents, and media were added to the wells in
a known volume of medium prior to GC, giving a final volume of
125 ml after addition of GC (2 3 105 GC/ml). DO and GC were
enerally cocultured for 24 h (except in the one experiment where
O were added for just 3 h; see Fig. 6) at a concentration of 16
O/well (0.128 DO/ml) unless otherwise stated. To produce
oocyte-conditioned medium (OCM), meiotically competent DO
were cultured in B-TCM for 24 h at 1.25 DO/ml in 96-well plates in
the absence of GC. Within each experiment, all treatments were
carried out in at least duplicate wells. Each experiment was
replicated on 4–6 occasions utilising ;6–12 mice per experimental
replicate. Cells were cultured in an atmosphere of 37°C, 96%
Copyright © 2001 by Academic Press. All righthumidity in 5% CO2 in air for 18 h, followed by a further 6-h pulse
of 15.4 kBq tritiated thymidine ([3H]thymidine; ICN).
Assessment of Oocytes and Cell Cultures
During or at the completion of culture, oocytes/zygotes were
visually assessed for developmental progression under an inverted
light microscope. Oocytes were classified as: immature (possessing
an intact germinal vesicle, GV), germinal vesicle breakdown (GVB),
metaphase II (MII; presence of a polar body, PB), fertilized (2
pronuclei present, 2PN), or as 2-cell embryos. At the completion of
culture, 80 ml of the culture media was collected and frozen
(220°C) for steroid analysis. Culture supernatants were assayed for
progesterone content by using a radioimmunoassay kit (Diagnostic
Systems Laboratories, Webster, TX) according to the manufactur-
er’s instructions. The kit, which utilises an 125I-labelled progester-
one tracer, has a sensitivity of 0.25 pmol/ml and an intra-assay
coefficient of variability of 5.4%. Following culture, GC were
harvested by using a Tomtec Harvester 96 onto a filtermat and
incorporated [3H]thymidine was quantified by using a Wallac
icrobeta scintillation counter. [3H] counts were used as a measure
of incorporation of [3H]thymidine into follicular cell DNA and as
n indicator of the proportion of cells in S-phase, hence providing
n indication of the level of GC DNA synthesis. In such experi-
ents, GC [3H]thymidine uptake does not necessarily afford a
recise measure of cell proliferation, but rather is a reflection of
hort-term cellular events that may be correlated with rates of cell
ivision. Previous studies have demonstrated that [3H]thymidine
uptake by GC is associated with an increase in total GC DNA
content when stimulated by oocytes (Lanuza et al., 1998), or in cell
numbers when stimulated by IGF-I in longer term cultures (Di
Blasio et al., 1994).
Statistcal Analysis
Within each experimental replicate, GC [3H]thymidine incorpo-
ration data were expressed as a fraction of the control treatment to
reduce between replicate variance. Data from GC [3H]thymidine
ncorporation were examined using either one-way or two-way
NOVAs and differences between treatment means tested by using
ukey–Kramer post hoc comparisons. Differences in the propor-
ion of oocytes undergoing GVB (see Fig. 2) were examined by using
hi-squared analysis.
RESULTS
Response of MGC to Denuded Oocytes and
Oocyte-Conditioned Medium
Coculturing MGC with DO increased MGC [3H]thymi-
ine incorporation in a dose-dependent manner (Fig. 1A). As
ew as 8 DO/125 ml well (0.064 DO/ml) led to a 2.5-fold
increase in MGC [3H] incorporation above control levels
P , 0.01) and at 62 DO/well levels were 16-fold higher than
ontrols. In the absence of DO, IGF-I caused a 1.7-fold
ncrease in MGC [3H] incorporation (P , 0.05). DO also
caused a dose-dependent increase in MGC DNA synthesis
in the presence of IGF-I (Fig. 1). Coculturing DO with MGC
also led to a dose-dependent increase in progesterone secre-
tion by MGC but only to levels 1.9-fold above control levels
s of reproduction in any form reserved.
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292 Gilchrist, Ritter, and Armstrong(Fig. 1B). In contrast, DO suppressed MGC progesterone
secretion when cultured in the presence of FSH (data not
shown), as previously reported (Vanderhyden et al., 1993).
Progesterone production was doubled by IGF-I alone and
increased 4-fold above control levels in the combined pres-
ence of IGF-I and 62 DO/well. The effects of DO and IGF-I
on MGC progesterone levels and DNA synthesis were
additive as no IGF-I 3 DO interaction was observed for
either variable (P . 0.05; two-way ANOVA).
Oocyte-conditioned medium (OCM), whether fresh
(Table 1) or frozen (data not shown), failed to alter the
incorporation of [3H]thymidine into MGC. In contrast,
oculture with DO at an equivalent concentration signifi-
antly (P , 0.001) increased [3H] incorporation above con-
trol levels. The failure of OCM to increase MGC [3H]
incorporation was also evident when oocyte concentrations
were increased to 62 DO/well (0.5 DO/ml), which leads to a
6-fold increase when oocytes are cocultured (Fig. 1). It has
reviously been shown that OCM is ineffective in inducing
roliferation (Lanuza et al., 1998) or suppressing LH recep-
FIG. 1. Dose response of denuded oocytes (DO) on mural granu-
losa cell DNA synthesis (A) and progesterone secretion (B). MGC
were cultured with increasing numbers of meiotically competent
DO either alone or together with 50 ng/ml IGF-I. Points represent
relative mean values 6 SEM expressed as a fraction of the control
(MGC in the absence of IGF-I and DO) from five replicate experi-
ments. There was no IGF-I 3 DO interaction (P . 0.05; two-way
ANOVA).or expression (Eppig et al., 1997), although the steroid-
Copyright © 2001 by Academic Press. All rightegulating capacity of oocytes is retained (Vanderhyden et
l., 1993).
Growth-Promoting Activity of Meiotically
Incompetent Oocytes
To examine whether meiotically incompetent oocytes
were able to promote granulosa cell DNA synthesis, oo-
cytes were collected from young prepubertal mice at an
age when follicular antrum development is incomplete.
Ovaries from 11- to 15-day-old mice have predominantly
preantral follicles containing growing, meiotically in-
competent oocytes (3.4% spontaneous germinal vesicle
breakdown [GVB] in vitro; Fig. 2). By 16 –19 days old,
follicles are at the periantral stage, and oocytes are growing
and are mostly meiotically incompetent (17.2% GVB). By
21 days of age, ovaries contain antral follicles with fully
grown, meiotically competent oocytes (95.4% GVB). Mei-
otically incompetent oocytes from 11- to 15- and 16- to
19-day-old mice were unable to promote [3H]thymidine
incorporation in MGC from 21- to 32-day-old mice (P .
0.05; Fig. 2). In contrast, coculture with competent, meioti-
cally maturing oocytes from 21- to 32-day-old mice signifi-
cantly increased MGC [3H] counts above control levels (P ,
.01).
To investigate the possibility that the failure of meioti-
ally incompetent oocytes to promote MGC growth is
ecause of a different state of differentiation of the GC, an
ge cross-over experiment was conducted by using rela-
ively undifferentiated GC from preantral follicles from 12-
o 15-day-old mice, and more differentiated MGC from 24-
o 28-day-old mice. Most notably, preantral GC had a
TABLE 1
Comparison of Coculture with Denuded Oocytes (DO) to
Culture with Fresh Oocyte-Conditioned Medium (OCM)
on MGC [3H]thymidine Incorporation
MGC plus: n oocytes/well
MGC [3H] incorporation
(Relative mean 6 SEM)
— 0 1.00 6 0.00a
OCM 8 1.35 6 0.19a
DO coculture 16 5.65 6 1.25b
OCM 16 1.38 6 0.11a
OCM 32 1.27 6 0.07a
OCM 64 1.55 6 0.32a
Note. Oocyte-conditioned medium (OCM) was generated by
culturing meiotically competent oocytes for 24 h at a concentra-
tion of 1.25 DO/ml. On the subsequent day, fresh OCM was diluted
out to the appropriate concentrations and added to freshly collected
MGC from 21- to 32-day-old mice. 64 DO/well 5 0.5 DO/ml. MGC
were cultured for 24 h either alone, in the presence of denuded
oocytes (DO), or with OCM freshly generated from the indicated
number of oocytes per well, and assessed for [3H] incorporation.
Means with different superscripts are significantly different (P ,
0.001).
s of reproduction in any form reserved.
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293Developmentally Coordinated Pattern of Oocyte Mitogenic Activityhigher base-line DNA synthetic capacity than MGC from
the older prepubertal mice (P , 0.05; Fig. 3). Meiotically
ncompetent oocytes from 12- to 15-day-old mice exhibited
o mitogenic activity, either on MGC or on preantral GC.
y contrast, meiotically competent oocytes were able to
timulate [3H]thymidine uptake by both GC types. Because
oocytes from 12- to 15-day-old mice are ;1/4 the volume of
fully grown oocytes and because the effects of oocytes on
GC act in a dose-dependent manner, an experiment was
conducted to compensate for this lower ooplasmic volume.
Consistent with the previous experiment, meiotically in-
competent oocytes, even with four times more oocytes than
the meiotically competent group, did not increase [3H]thy-
midine counts above control levels (Table 2). Together,
these results demonstrate that the mitogenic capacity of
oocytes is acquired concomitant with the acquisition of
meiotic competence.
Growth-Promoting Activity of GV-Arrested
Oocytes, Maturing Oocytes, and Zygotes
A comparison of mitogenic activity of meiotically com-
petent GV-stage oocytes with in vitro maturing oocytes, in
vivo matured (ovulated) oocytes, and zygotes is shown in
Fig. 4. Meiotically competent oocytes stimulated GC DNA
FIG. 2. Effect of meiotic competence of oocytes on DO-
stimulated MGC [3H]thymidine incorporation. MGC from 21- to
32-day-old mice were cultured either alone or in the presence of
DO with varying degrees of meiotic competence collected from
mice of increasing age prepuberty. The same oocytes were assessed
for meiotic resumption (germinal vesicle breakdown, GVB) at the
end of the 24-h culture (numbers above bars represent number of
oocytes meiotically assessed). Oocytes from 11- to 15-day-old mice
were cultured at double the concentration of the other treatments
to compensate for their smaller volume. Bars represent relative
mean values 6 SEM expressed as a fraction of the control (MGC in
the absence of DO) from five replicate experiments. *, Significantly
different to all other treatments (P , 0.01). Bars with no common
superscripts are significantly different (P , 0.001).synthesis in a developmentally regulated pattern, with the
Copyright © 2001 by Academic Press. All righthighest levels in immature, GV-stage oocytes, and levels
progressively declining toward the end of and after meiotic
maturation. GV-stage oocytes displayed significantly
higher growth-promoting activity than MII-stage oocytes
and zygotes (P , 0.01). Meiotically competent oocytes
aintained in meiotic arrest by culture with 5 mM milri-
one, tended to exhibit the greatest capacity of oocytes at
ny developmental stage (Fig. 4). This was on average 1.5
imes higher than oocytes undergoing meiotic maturation,
lthough this difference was not significantly different
Fig. 4).
FIG. 3. Effect of state of differentiation of GC (granulosa cell) and
oocyte meiotic competence on DO-stimulated GC [3H]thymidine
incorporation. GC from either 12- to 15-day-old or 24- to 28-day-old
mice were cultured with either meiotically incompetent oocytes
(from 12- to 15-day-old mice) or meiotically competent oocytes
(from 24- to 28-day-old mice) and assessed for [3H] incorporation
fter 24 h. Bars represent relative mean values 6 SEM expressed as
fraction of the control (24- to 28-day-old GC in the absence of DO)
rom four experiments. Bars within a GC age group with no
ommon superscripts are significantly different (P , 0.05).
ABLE 2
ffect of Denuded Oocytes (DO) on DNA Synthesis in Granulosa
ells from 12- to 14-Day-Old Mice: Comparison of Meiotically
ompetent Versus Incompetent Denuded Oocytes
Meiotic competence of
cocultured oocytes n oocytes/well
GC [3H] incorporation
(Relative mean 6 SEM)
— 0 1.00 6 0.00a
Competent 16 2.31 6 0.25b
Incompetent 16 1.11 6 0.11a
Incompetent 64 0.96 6 0.09a
Note. Meiotically competent oocytes were collected from 21- to
32-day-old mice, whereas incompetent oocytes were from 12- to
14-day-old mice. Granulosa cells (GC) from 12- to 14-day-old mice
were cultured for 24 h with both oocyte types and assessed for [3H]
incorporation. Means with different superscripts are significantly
different (P , 0.001).
s of reproduction in any form reserved.
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294 Gilchrist, Ritter, and ArmstrongTo confirm the oocyte specificity of milrinone, GC were
cultured with various concentrations of milrinone without
oocytes (Fig. 5). There was no effect of milrinone (P . 0.05),
even at concentrations as high as 125 mM, on the incorpo-
ation of thymidine into either MGC alone, or on DO-
timulated incorporation into MGC. Hence the elevated
GC [3H] incorporation can be specifically attributed to
he activity of GV oocytes and not due to the milrinone
reatment, as no milrinone 3 GV–oocyte interaction was
bserved (P . 0.05; two-way ANOVA). Milrinone concen-
rations as low as 1 mM were sufficient to maintain 82% of
ocytes at the GV stage, compared to only 12% of control
ocytes (0 mM milrinone). As was also observed in Fig. 4,
DO-stimulated [3H] incorporation in MGC was marginally
lower (P . 0.05) in the presence of meiotically maturing
oocytes (0 mM milrinone) than with GV-arrested oocytes
(1–125 mM milrinone; Fig. 5).
To examine the growth-promoting activity of oocytes
uring defined periods of meiotic maturation, oocytes were
recultured for 0, 3, 6, or 9 h to produce four groups of
ocytes, each at progressively advanced stages of meiosis.
fter the designated period of preculture, oocytes were then
dded to freshly collected MGC for just 3 h, thereby
xposing MGC to oocytes at different stages of meiotic
aturation (Fig. 6). The capacity of oocytes to promote
GC [3H] incorporation progressively declined over the
12-h period of meiotic maturation. Oocytes undergoing
GVB had the equivalent capacity to promote [3H] incorpo-
ation as oocytes undergoing the diakinesis-to-metaphase I
FIG. 4. Comparison of oocytes/zygotes at different stages of
evelopment on their capacity to stimulate MGC [3H]thymidine
incorporation. MGC from 24- to 32-day-old mice were cocultured
with either milrinone-arrested germinal vesicle-stage (GV) oocytes,
in vitro maturing oocytes, metaphase II (MII) ovulated ova, or
one-cell zygotes. Bars represent relative mean values 6 SEM
expressed as a fraction of the control (MGC alone). Bars with no
common superscripts are significantly different (P , 0.05).ransition. The growth-promoting activity of oocytes de-
Copyright © 2001 by Academic Press. All rightlined most markedly in the final phase of oocyte matura-
ion as oocytes approached metaphase II (MII; P , 0.05). To
nsure that this decline was not an artefact of oocyte in
itro maturation, a comparison was made between oocytes
atured in vitro and in vivo (Table 3). MII oocytes, whether
atured in vitro or in vivo, had equivalent capacities to
romote MGC [3H] incorporation. In all three experiments,
[3H] counts in the presence of MII oocytes were ;50% that
f meiotically maturing oocytes (Figs. 4 and 6, Table 3).
itogenic capacity declined even further after fertilization
f mature oocytes, with undetectable levels from zygotes
Fig. 4).
DISCUSSION
This study demonstrates that the growth-promoting ac-
tivity of oocytes is developmentally coordinated through-
out folliculogenesis and oocyte maturation. Perhaps most
surprisingly, growing oocytes from preantral follicles do not
appear to promote proliferation of granulosa cells, with
oocytes first acquiring this capacity at the end of their
growth phase. The most potent modulators of granulosa
cell DNA synthesis are fully grown GV oocytes which
secrete a mitogen throughout antral follicle development.
Upon the resumption of meiosis, whether in vivo or in
vitro, oocyte mitogenic capacity starts to fall and reaches
FIG. 5. Lack of interaction between milrinone treatment and
GV-stage oocytes. MGC from 24- to 32-day-old mice were cultured
with increasing concentrations of the type-3 phosphodiesterase
inhibitor, milrinone, either alone or in the presence of 16 DO. In
the absence of milrinone, denuded oocytes underwent germinal
vesicle breakdown (GVB) during the culture period, whereas at all
milrinone concentrations, .90% of oocytes were maintained in
meiotic arrest. Points represent relative mean values 6 SEM
expressed as a fraction of the control (MGC in the absence of DO or
milrinone). No milrinone 3 GV-oocyte interaction was observed
(two-way ANOVA). Dose of milrinone had no effect on [3H]thymi-
ine incorporation in MGC alone or in DO-stimulated MGC.
enuded oocytes significantly increased MGC [3H]thymidine in-corporation above MGC alone (P , 0.0001).
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295Developmentally Coordinated Pattern of Oocyte Mitogenic Activitybase-line levels after fertilisation. This expression profile is
somewhat unusual because the developmental pattern of
oocyte mitogenic activity is the converse of oocyte tran-
scriptional activity. For example, growing oocytes and mei-
otically maturing oocytes have higher rates of transcription
than fully grown GV-arrested oocytes (de Smedt et al., 1994;
air et al., 1995). GV oocytes in antral follicles are at a
elatively quiescent phase of development as indicated by
FIG. 6. Effect of stage of meiosis on the capacity of DO to
stimulate MGC [3H]thymidine incorporation. MGC from 24- to
8-day-old mice were exposed to denuded oocytes for 3 h at defined
tages of meiotic maturation; either oocytes undergoing germinal
esicle breakdown, reaching MI, undergoing the MI-AI transition,
r completing meiotic maturation. To achieve this, groups of 50
ocytes were precultured for either 9 h (treatment 1), 6 h (treatment
), 3 h (treatment 3), or 0 h (treatment 4), then added to fresh MGC
or just 3 h before being removed from wells. The remaining MGC
ere cultured for a further 21 h and then assessed for [3H]
incorporation. Bars represent relative mean values 6 SEM ex-
pressed as a fraction of the control (MGC in the absence of DO).
Bars with no common superscripts are significantly different (P ,
0.05).ondensed chromatin configurations and compact nucleoli
Copyright © 2001 by Academic Press. All rightCrozet, 1989; Mattson and Albertini, 1990). Yet in this
tudy, it is precisely these oocytes that exhibit the highest
itogenic activity, indicating that the growth-promoting
ctivity of oocytes is differentially regulated from general
ocyte synthetic activity.
This study has shown that growing, meiotically incom-
etent oocytes are unable to promote the proliferation of
ranulosa cells from either preantral or antral follicles. Both
ranulosa cell types are, however, responsive to an oocyte
itogen as evidenced by promotion of GC thymidine
ncorporation by meiotically competent oocytes. This sug-
ests that the oocyte may not be a major promoter of the
rowth of preantral granulosa cells, and that perhaps nonoo-
yte paracrine factors are driving the earlier stages of
olliculogenesis. Oocytes from preantral follicles do, how-
ver, contain GDF-9 (Elvin et al., 1999; Jaatinen et al., 1999)
nd BMP-15 proteins (Otsuka et al., 2000), both of which
are potent GC mitogens (Otsuka et al., 2000; Vitt et al.,
2000a). Furthermore, oocyte GDF-9 and BMP-15 are prereq-
uisites for follicle growth beyond the primary stage in mice
(Dong et al., 1996) and sheep (Galloway et al., 2000),
respectively. GDF-9 also stimulates rodent preantral fol-
licle growth both in vitro (Hayashi et al., 1999) and in vivo
(Vitt et al., 2000b). These studies demonstrate that prean-
tral follicles are responsive to GDF-9 and BMP-15 and that
oocyte-secreted GDF-9 and BMP-15 are key regulators of
early folliculogenesis.
However, results of the present and of other studies
indicate that activities of oocyte-secreted factors cannot be
fully attributed to GDF-9 and BMP-15 activities. For ex-
ample, recombinant GDF-9 suppresses KL mRNA expres-
sion in both preantral GC and MGC, yet oocytes from
preantral follicles are not able to suppress KL levels, in
contrast to fully grown oocytes from antral follicles (Joyce
et al., 2000). Similarly, GC mucification is promoted and
uPA expression is suppressed by GDF-9 and fully grown
oocytes, but not by growing oocytes (Vanderhyden et al.,
1990; Canipari et al., 1995; Elvin et al., 1999). These
findings parallel the situation with the oocyte mitogen: GC
TABLE 3
Mitogenic Capacity of in Vivo Versus in Vitro Matured Oocytes
Nuclear status of
cocultured oocytes
MGC [3H] incorporation
(Relative mean 6 SEM)
— 1.00 6 0.00a
In vitro maturing 16.15 6 2.08b
MII—in vitro matured 9.15 6 0.59c
MII—ovulated 7.69 6 0.82c
c
Note. MGC from 21- to 32-day-old mice were cultured either
alone, with oocytes undergoing meiotic maturation (freshly iso-
lated at the GV-stage), or with meiotically mature oocytes either in
vivo or in vitro matured in the previous 12 h. Means with different
superscripts are significantly different (P , 0.01).
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296 Gilchrist, Ritter, and Armstrongproliferation is promoted by GDF-9, BMP-15, and fully
grown oocytes (Vanderhyden et al., 1992; Otsuka et al.,
2000; Vitt et al., 2000a), but not by growing meiotically
incompetent oocytes (present study). Therefore, although
GC from preantral follicles are responsive to GDF-9, BMP-
15, and factors from fully grown oocytes, in general, oocytes
from preantral follicles do not elicit a GC response. If the
effects of fully grown oocytes are mediated through GDF-9,
BMP-15 or a heterodimer of the two, then the GDF-9 and
BMP-15 present in growing oocytes must have limited
biological activity, at least in terms of mitogenic activity,
promoting mucification, or suppressing uPA levels. Al-
though GDF-9 and BMP-15 proteins have been detected in
oocytes by using immunohistochemistry, thus far there is
no report of actual secretion of biologically active GDF-9 or
BMP-15 by oocytes. Perhaps the GDF-9 and BMP-15 pro-
teins detected in growing oocytes are not actively secreted,
or are secreted in their biologically inactive preproprotein
forms. Clearly GDF-9 and BMP-15 are critical for follicle
transition beyond the primary stage, but their roles in
preantral follicle growth may require further clarification.
In this study, oocytes with the highest mitogenic activity
were fully grown, GV-stage oocytes. Meiotic resumption of
competent oocytes was artificially inhibited by treatment
with milrinone, a selective inhibitor of type-3 cyclic nucle-
otide phosphodiesterases. These experiments exploited the
fact that different cell types within rodent follicles contain
different phosphodiesterase isotypes; that is, oocytes con-
tain type-3B phosphodiesterase while follicular somatic
cells contain type 4D (Tsafriri et al., 1996). When studying
oocyte–follicular cell interactions, inhibiting meiosis using
an oocyte-specific type-3 phosphodiesterase inhibitor has
the advantage over other commonly used noncell-type-
specific agents such as 3-isobutyl methylxanthine (IBMX)
or cycloheximide, as the function of follicular cells is not
effected by the meiotic inhibitor.
The growth-promoting activity of oocytes is attained
once oocytes have completed their growth phase and have
acquired meiotic competence. The mitogenic activity of
oocytes was higher in fully grown, GV-arrested oocytes
than in oocytes from any other stage of development. This
is noteworthy because, in general terms, this is a relatively
quiescent stage of oogenesis. At this stage of development,
oocytes have completed their growth phase and rates of
transcription are notably less than in growing oocytes or
meiotically maturing oocytes. This stage of oogenesis per-
sists approximately from early antrum formation through
antral development up to the preovulatory-stage of follicle
development. During this stage, both cumulus cells and
MGC are able to respond to the oocyte mitogen (Li et al.,
2000; present study); however, presumably cumulus cells
are the primary recipients. This concept is supported by the
fact that bovine COC have a much higher proliferative
capacity than MGC, and cumulus cells are more sensitive
than MGC to the oocyte mitogen (Li et al., 2000). Further-
more, radiolabelling in antral follicles of rats infused with
[3H]thymidine is highest in the COC and the surrounding t
Copyright © 2001 by Academic Press. All rightGC, and lowest in MGC on the opposite side of the
ollicle (Hirshfield, 1986). These data suggest that a mor-
hogenic gradient of oocyte-secreted factors exists across
he antral follicle and that in general, MGC are either not
xposed to the paracrine actions of oocytes or have some
echanism to neutralise their effects. These ideas are in
eeping with the hypothesis that the default pathway of
ollicular cell development is towards the MGC phenotype
nd that the oocyte actively promotes development of the
umulus cell phenotype (Eppig et al., 1997; Li et al., 2000).
aintenance of a specialised oocyte–cumulus cell micro-
nvironment throughout antral development by oocyte
actors may constitute an important component of oocyte
ytoplasmic maturation and hence oocyte developmental
apacity.
Meiotic resumption marks the beginning of the end of
ecretion of a growth-promoting factor by the oocyte. After
eiotic resumption, oocytes continue to secrete a granu-
osa cell mitogen at roughly constant levels for the first 6 h
nd then activity progressively declines to undetectable
evels by the zygotic stage. Hence oocytes are actively
ecreting a mitogen during a critical phase of oocyte devel-
pment, when the oocyte is undergoing dramatic changes
n its cell program, including meiotic maturation and
emodelling of the surrounding cumulus investments.
ther oocyte-regulated activities such as steroid secretion,
nd suppression of uPA and LHR mRNA expression are all
aintained to some extent by metaphase II oocytes, but are
hen absent in the early zygote (Canipari et al., 1995; Eppig
et al., 1997; Vanderhyden and Macdonald, 1998). The de-
velopmental expression of oocyte CEEF is also tightly
regulated during meiotic maturation. Fully grown mouse
oocytes secrete CEEF when arrested at the GV stage and
during meiotic maturation, but not after fertilization
(Vanderhyden et al., 1990). It seems reasonable that the
ontinued production of all of these oocyte factors during
ocyte maturation is important for remodelling of the
umulus investments in preparation for ovulation and
ertilization. This includes precise regulation of cumulus
ell steroidogenesis, expansion of the cumulus cell mass
nd withdrawal of the oocyte–cumulus cell cytoplasmic
rocesses, and maintenance of extracellular-matrix stabil-
ty by inhibiting local protease activity. However, it is less
lear what the function of an oocyte-secreted mitogen
ight be during meiotic maturation, as opposed to during
ntral development, when the oocyte-mitogen is required
o maintain the microenvironment of the oocyte–cumulus
ell complex distinct from that of the MGC (Li et al., 2000).
erhaps secretion of the oocyte-mitogen during meiosis
erves some, as yet undetermined role, or alternatively
ecretion during meiotic maturation may just represent
esidual activity from when the oocyte was arrested at the
V stage. This notion is supported by the fact that soon
fter meiotic resumption, oocyte mitogen levels progres-
ively decline during and after oocyte maturation.
This study has shown that the capacity of mouse oocyteso promote growth of granulosa cells is regulated in a
s of reproduction in any form reserved.
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297Developmentally Coordinated Pattern of Oocyte Mitogenic Activitydevelopmentally coordinated manner. The failure of mei-
otically incompetent oocytes to promote growth is incon-
sistent with the predicted role of oocyte-secreted GDF-9
and BMP-15 in early folliculogenesis. The developmental
expression pattern of the oocyte mitogen is however con-
sistent with many other oocyte-secreted factors, with ac-
tivities being first attained as oocytes acquire meiotic
capacity, maintaining high expression levels throughout
antral development, and then falling after meiotic matura-
tion. This expression profile adds further support to the
growing body of evidence that oocytes secrete these para-
crine factors from around the time of antrum formation
until ovulation, to establish and maintain an immediate
microenvironment which is distinct from that of the rest of
the follicle.
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